Prospective Observational Cohort HIV & STI Study in Europe

CompletedOBSERVATIONAL
Enrollment

3,593

Participants

Timeline

Start Date

April 24, 2019

Primary Completion Date

August 22, 2022

Study Completion Date

August 22, 2022

Conditions
HIV InfectionsHIV-1-infectionRisk ReductionSexual Behavior
Interventions
BEHAVIORAL

Determine the Incidence and Point Prevalence

Determine the Incidence and Point Prevalence of human immunodeficiency virus (HIV) Infection and the Most Common Sexually Transmitted Infections in Individuals With Sexual Risk Behavior.

Trial Locations (15)

Unknown

Centre Hospitalier Universitaire de Bordeaux, Bordeaux

Hôpital de la Croix-Rousse, Lyon

Hospital Saint Louis, Paris

Hôpital Lariboisière, Paris

Hôpital Saint-Antoine, Paris

Semmelweis University, Budapest

Hospital Maggiore Policlinico, Milan

Hospital San Raffaele, Milan

National Institute for Infectious Diseases L. Spallanzani, Rome

Centrum PrEP Gdańsk, Gdansk

Pomeranian Medical University, Szczecin

Chmielna Express Warsaw, Warsaw

Center for Prevention and Treatment of Infectious Diseases and Addiction Treatment, Wroclaw

Hospital Universitari Germans Trias i Pujol, Barcelona

Vall d'Hebron Research Institute, Barcelona

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Hendrik Streeck

OTHER

NCT03866759 - Prospective Observational Cohort HIV & STI Study in Europe | Biotech Hunter | Biotech Hunter